When did Alkermes report Q3 2024 earnings?

Alkermes (ALKS) reported Q3 2024 earnings on October 24, 2024 before market open.

What were Alkermes's Q3 2024 revenue and EPS?

Alkermes reported revenue of $378.1M and eps of $0.72 for Q3 2024.

Did Alkermes beat estimates in Q3 2024?

Revenue missed the consensus estimate of $381.4M by $3.2M. EPS missed the consensus estimate of $0.74 by $0.02.

Where can I find Alkermes's Q3 2024 SEC filings?

You can read the 10-Q periodic report (0000950170-24-116872) directly on SEC EDGAR. The filing index links above go to sec.gov.

Alkermes ALKS Q3 2024 earnings

Reported October 24, 2024 · Before market open

Revenue$378.1MMiss by $3.2M

EPS$0.72Miss by $0.02

Revenue estimate$381.4M

EPS estimate$0.74

Next report

Oct 27, 2026 (in 3 months)

Revenue estimate$467.0M

EPS estimate$0.01

Financials

Q3 2024

Income statement

See full

Revenue$378.1M-0.7%

Gross profit$315.0M-1.4%

Operating income$104.8M+139%

Net income$92.4M+93.4%

EPS (diluted)$0.55+96.4%

Balance sheet

See full

Cash & equivalents$396.3M-38.8%

Total debt$366.0M-4.9%

Total equity$1.3B-4.7%

Total assets$2.2B-5.4%

Cash flow

See full

Operating cash flow$81.6M-18.2%

CapEx$8.3M-42.9%

Free cash flow$73.3M-14.0%

Valuation & ratios

Valuation

as of 09/30/24

See full

Market cap$4.61B-1.2%

Enterprise value$4.58B+4.0%

P/E13.8×-7.9×

P/S3.1×+0.1×

Profitability

See full

Gross margin83.2%-1.9pp

Operating margin29%+15.5pp

Net margin22.1%+8.6pp

FCF margin20.9%+5.0pp

Returns & leverage

See full

Return on equity25.2%+7.3pp

Debt / equity0.3×0.0×

Current ratio3.4×+0.5×

Segments

By product

See full

Vivitrol$113.7M—

Aristada And Aristada Initio$84.7M—

LYBALVI$74.7M—

By geography

See full

US$352.5M-5.5%

IE$323.5K+9.8%

Versus estimates

Revenue

Q2 2026$496.0MBeat by $38.6M Q1 2026$392.9MBeat by $29.9M Q4 2025$384.5MBeat by $5.6M Q3 2025$394.2MBeat by $14.3M Q2 2025$390.7MBeat by $36.1M Q1 2025$306.5MBeat by $3.6M

Diluted EPS

Q2 2026$0.70Beat by $0.73 Q1 2026-$0.40Beat by $0.17 Q4 2025$0.34Miss by $0.09 Q3 2025$0.49Beat by $0.07 Q2 2025$0.52Beat by $0.11 Q1 2025$0.13Miss by $0.12

Ask the moment Alkermes reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Alkermes report Q3 2024 earnings?: Alkermes (ALKS) reported Q3 2024 earnings on October 24, 2024 before market open.
What were Alkermes's Q3 2024 revenue and EPS?: Alkermes reported revenue of $378.1M and eps of $0.72 for Q3 2024.
Did Alkermes beat estimates in Q3 2024?: Revenue missed the consensus estimate of $381.4M by $3.2M. EPS missed the consensus estimate of $0.74 by $0.02.
Where can I find Alkermes's Q3 2024 SEC filings?: You can read the 10-Q periodic report (0000950170-24-116872) directly on SEC EDGAR. The filing index links above go to sec.gov.